LEVETIRACETAM IN SODIUM CHLORIDE

LEVETIRACETAM IN SODIUM CHLORIDE was reported 78636 times

These side effects are most commonly reported by patients taking LEVETIRACETAM IN SODIUM CHLORIDE:

# Side effect Count
0 DRUG INEFFECTIVE 9213
1 SEIZURE 8983
2 OFF LABEL USE 6638
3 MATERNAL EXPOSURE DURING PREGNANCY 3194
4 EPILEPSY 2826
5 FOETAL EXPOSURE DURING PREGNANCY 2642
6 DRUG INTERACTION 2532
7 FATIGUE 2500
8 CONDITION AGGRAVATED 2341
9 SOMNOLENCE 2130
10 STATUS EPILEPTICUS 2102
11 GENERALISED TONIC-CLONIC SEIZURE 2051
12 TOXICITY TO VARIOUS AGENTS 1890
13 FALL 1864
14 DIZZINESS 1783
15 HEADACHE 1701
16 NAUSEA 1644
17 PYREXIA 1606
18 ABORTION SPONTANEOUS 1596
19 DEATH 1577
20 DIARRHOEA 1544
21 VOMITING 1449
22 PNEUMONIA 1364
23 CONFUSIONAL STATE 1351
24 MULTIPLE-DRUG RESISTANCE 1307
25 AGGRESSION 1296
26 ACUTE KIDNEY INJURY 1290
27 CONVULSION 1278
28 RASH 1226
29 THROMBOCYTOPENIA 1225
30 RHABDOMYOLYSIS 1222
31 OVERDOSE 1169
32 HYPOTENSION 1136
33 PRODUCT USE IN UNAPPROVED INDICATION 1123
34 ASTHENIA 1122
35 DEPRESSION 1121
36 ANXIETY 1055
37 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1053
38 EXPOSURE DURING PREGNANCY 1044
39 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1013
40 AGITATION 987
41 DECREASED APPETITE 942
42 PARTIAL SEIZURES 938
43 GAIT DISTURBANCE 937
44 INSOMNIA 937
45 IRRITABILITY 931
46 TREMOR 910
47 WEIGHT DECREASED 869
48 DYSPNOEA 863
49 DRUG RESISTANCE 862
50 PRODUCT USE ISSUE 846
51 MEMORY IMPAIRMENT 833
52 COGNITIVE DISORDER 814
53 PAIN 800
54 MALAISE 757
55 TREATMENT FAILURE 757
56 NO ADVERSE EVENT 736
57 RESPIRATORY FAILURE 707
58 HYPONATRAEMIA 702
59 CARDIAC ARREST 696
60 LOSS OF CONSCIOUSNESS 694
61 NEUTROPENIA 692
62 ENCEPHALOPATHY 682
63 ANAEMIA 671
64 GENERAL PHYSICAL HEALTH DETERIORATION 669
65 PRODUCT SUBSTITUTION ISSUE 668
66 SUICIDAL IDEATION 666
67 PETIT MAL EPILEPSY 661
68 HALLUCINATION 653
69 URINARY TRACT INFECTION 650
70 INTENTIONAL OVERDOSE 640
71 WEIGHT INCREASED 636
72 PRODUCT DOSE OMISSION ISSUE 630
73 PREGNANCY 620
74 PRURITUS 594
75 DISEASE PROGRESSION 588
76 ANGER 578
77 DEPRESSED LEVEL OF CONSCIOUSNESS 572
78 SEPSIS 568
79 BALANCE DISORDER 565
80 CONSTIPATION 560
81 COUGH 559
82 ABNORMAL BEHAVIOUR 539
83 METABOLIC ACIDOSIS 533
84 ATAXIA 530
85 RENAL FAILURE 527
86 CYTOKINE RELEASE SYNDROME 526
87 DELIRIUM 525
88 BRADYCARDIA 522
89 COMPLETED SUICIDE 517
90 PSYCHOTIC DISORDER 514
91 MYOCLONUS 513
92 DISTURBANCE IN ATTENTION 508
93 FEELING ABNORMAL 506
94 PANCYTOPENIA 506
95 SUICIDE ATTEMPT 505
96 HOSPITALISATION 504
97 ABDOMINAL PAIN 502
98 TACHYCARDIA 501
99 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 497
100 THERAPY NON-RESPONDER 497
101 CEREBROVASCULAR ACCIDENT 495
102 TREATMENT NONCOMPLIANCE 495
103 DYSPHAGIA 491
104 HYPOKALAEMIA 490
105 HYPERTENSION 488
106 DRUG INTOLERANCE 483
107 ARTHRALGIA 476
108 APHASIA 473
109 COMA 461
110 MUSCULAR WEAKNESS 459
111 MULTIPLE ORGAN DYSFUNCTION SYNDROME 458
112 BEHAVIOUR DISORDER 449
113 DEHYDRATION 449
114 PREMATURE BABY 447
115 SYNCOPE 443
116 MENTAL STATUS CHANGES 440
117 AMNESIA 434
118 TOXIC EPIDERMAL NECROLYSIS 428
119 PARAESTHESIA 426
120 INTENTIONAL PRODUCT MISUSE 420
121 STEVENS-JOHNSON SYNDROME 419
122 ELECTROCARDIOGRAM QT PROLONGED 415
123 PAIN IN EXTREMITY 412
124 DISORIENTATION 410
125 PNEUMONIA ASPIRATION 406
126 ERYTHEMA 402
127 INFECTION 396
128 SLEEP DISORDER 396
129 SPEECH DISORDER 396
130 DYSARTHRIA 395
131 BACK PAIN 393
132 PLATELET COUNT DECREASED 391
133 DYSKINESIA 387
134 LEUKOPENIA 384
135 FEBRILE NEUTROPENIA 383
136 MOOD SWINGS 379
137 ALTERED STATE OF CONSCIOUSNESS 372
138 ALOPECIA 369
139 LETHARGY 368
140 SEDATION 365
141 DEPRESSED MOOD 364
142 CONGENITAL ANOMALY 363
143 OXYGEN SATURATION DECREASED 359
144 DRUG HYPERSENSITIVITY 354
145 ADVERSE DRUG REACTION 352
146 HYPERSENSITIVITY 350
147 DRUG-INDUCED LIVER INJURY 348
148 ALANINE AMINOTRANSFERASE INCREASED 344
149 CEREBRAL HAEMORRHAGE 343
150 MUCOSAL INFLAMMATION 343
151 CHEST PAIN 339
152 MUSCLE SPASMS 335
153 DRUG LEVEL INCREASED 331
154 STILLBIRTH 331
155 COVID-19 327
156 RENAL IMPAIRMENT 327
157 VISION BLURRED 326
158 PREMATURE DELIVERY 325
159 MEDICATION ERROR 319
160 MALIGNANT NEOPLASM PROGRESSION 315
161 HYPERAMMONAEMIA 312
162 RESTLESSNESS 312
163 HALLUCINATION, VISUAL 311
164 HYPOAESTHESIA 310
165 TUBULOINTERSTITIAL NEPHRITIS 307
166 BLOOD CREATINE PHOSPHOKINASE INCREASED 306
167 FOCAL DYSCOGNITIVE SEIZURES 304
168 BLOOD PRESSURE INCREASED 303
169 MYOCLONIC EPILEPSY 303
170 MOOD ALTERED 299
171 HAEMOGLOBIN DECREASED 295
172 NEUROTOXICITY 292
173 PERIPHERAL SWELLING 290
174 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 289
175 INCORRECT DOSE ADMINISTERED 287
176 ABDOMINAL PAIN UPPER 286
177 EOSINOPHILIA 285
178 GRAND MAL CONVULSION 283
179 RASH MACULO-PAPULAR 283
180 SEPTIC SHOCK 280
181 UNRESPONSIVE TO STIMULI 279
182 WHITE BLOOD CELL COUNT DECREASED 279
183 MENTAL DISORDER 278
184 URTICARIA 278
185 INTENTIONAL PRODUCT USE ISSUE 276
186 PARADOXICAL DRUG REACTION 276
187 CHRONIC KIDNEY DISEASE 275
188 MYALGIA 274
189 DRUG ABUSE 273
190 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 273
191 LOW BIRTH WEIGHT BABY 273
192 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 270
193 ATRIAL FIBRILLATION 267
194 DISEASE RECURRENCE 267
195 NEUROPATHY PERIPHERAL 267
196 OEDEMA PERIPHERAL 267
197 ASPARTATE AMINOTRANSFERASE INCREASED 261
198 ATRIAL SEPTAL DEFECT 261
199 CHILLS 261
200 DIPLOPIA 261
201 HEPATIC ENZYME INCREASED 260
202 HYPOMAGNESAEMIA 260
203 BRAIN OEDEMA 259
204 PSYCHOGENIC SEIZURE 259
205 HEPATIC FUNCTION ABNORMAL 258
206 ABORTION INDUCED 257
207 HEAD INJURY 257
208 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 257
209 CARDIO-RESPIRATORY ARREST 256
210 PSYCHOMOTOR HYPERACTIVITY 255
211 APLASTIC ANAEMIA 250
212 NASOPHARYNGITIS 250
213 BLOOD CREATININE INCREASED 249
214 MIGRAINE 248
215 HALLUCINATION, AUDITORY 247
216 VISUAL IMPAIRMENT 247
217 HYPERHIDROSIS 242
218 HYPOXIA 242
219 ELECTROENCEPHALOGRAM ABNORMAL 240
220 DELUSION 233
221 ACUTE HEPATIC FAILURE 232
222 CONTUSION 232
223 VERTIGO 230
224 HEMIPARESIS 229
225 BLISTER 226
226 EPISTAXIS 225
227 MOBILITY DECREASED 224
228 SMALL FOR DATES BABY 222
229 ACCIDENTAL OVERDOSE 219
230 MUSCLE TWITCHING 219
231 ABDOMINAL DISTENSION 218
232 DEEP VEIN THROMBOSIS 218
233 GASTROINTESTINAL HAEMORRHAGE 216
234 VENTRICULAR SEPTAL DEFECT 216
235 PANCREATITIS 213
236 PULMONARY EMBOLISM 212
237 UNEVALUABLE EVENT 212
238 ABDOMINAL DISCOMFORT 211
239 VENTRICULAR TACHYCARDIA 211
240 INFLUENZA 210
241 INFLUENZA LIKE ILLNESS 210
242 STRESS 210
243 ADVERSE EVENT 207
244 CHOLESTASIS 207
245 OROPHARYNGEAL PAIN 207
246 PARKINSONISM 206
247 URINARY RETENTION 205
248 HEART RATE INCREASED 203
249 PLEURAL EFFUSION 203
250 COORDINATION ABNORMAL 202
251 GASTROINTESTINAL DISORDER 202
252 DRUG LEVEL DECREASED 200
253 THINKING ABNORMAL 200
254 HYPOGLYCAEMIA 199
255 INTENTIONAL SELF-INJURY 198
256 PRODUCT DOSE OMISSION 197
257 HAEMORRHAGE 195
258 RESPIRATORY DISTRESS 195
259 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 194
260 HYPERSOMNIA 193
261 PARANOIA 193
262 DRUG EXPOSURE DURING PREGNANCY 192
263 PALPITATIONS 192
264 THERAPY INTERRUPTED 191
265 THERAPEUTIC RESPONSE DECREASED 190
266 AURA 189
267 DRUG ERUPTION 189
268 INTERSTITIAL LUNG DISEASE 188
269 DRUG DOSE OMISSION 186
270 GASTROOESOPHAGEAL REFLUX DISEASE 186
271 MATERNAL EXPOSURE BEFORE PREGNANCY 186
272 HYPOCALCAEMIA 185
273 UNDERDOSE 185
274 SEROTONIN SYNDROME 184
275 THERAPY PARTIAL RESPONDER 184
276 BLOOD GLUCOSE INCREASED 183
277 CRYING 183
278 HEPATITIS 183
279 PRODUCT ADMINISTRATION ERROR 183
280 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 181
281 CARDIAC FAILURE 180
282 TRANSAMINASES INCREASED 180
283 NERVOUS SYSTEM DISORDER 179
284 OEDEMA 179
285 GAMMA-GLUTAMYLTRANSFERASE INCREASED 178
286 TONIC CONVULSION 178
287 HEPATOTOXICITY 176
288 MYOCARDIAL INFARCTION 176
289 CHANGE IN SEIZURE PRESENTATION 175
290 DEVELOPMENTAL DELAY 175
291 ANTICONVULSANT DRUG LEVEL DECREASED 174
292 ILLNESS 174
293 RASH ERYTHEMATOUS 174
294 CIRCULATORY COLLAPSE 173
295 PANIC ATTACK 172
296 MANIA 171
297 TOXIC ENCEPHALOPATHY 171
298 HEPATIC CYTOLYSIS 170
299 HEPATOCELLULAR INJURY 169
300 MUSCULOSKELETAL STIFFNESS 169
301 STOMATITIS 169
302 LEUKOCYTOSIS 168
303 URINARY INCONTINENCE 168
304 HYPERAMMONAEMIC ENCEPHALOPATHY 166
305 HEPATIC FAILURE 165
306 LYMPHOPENIA 165
307 METASTASES TO CENTRAL NERVOUS SYSTEM 165
308 ACUTE RESPIRATORY FAILURE 164
309 ARRHYTHMIA 163
310 NERVOUSNESS 162
311 LACTIC ACIDOSIS 161
312 ANTICONVULSANT DRUG LEVEL INCREASED 160
313 C-REACTIVE PROTEIN INCREASED 159
314 MOVEMENT DISORDER 159
315 SUBDURAL HAEMATOMA 159
316 APATHY 158
317 DYSPEPSIA 158
318 AFFECTIVE DISORDER 156
319 ANGIOEDEMA 156
320 BLOOD PRESSURE DECREASED 156
321 PERSONALITY CHANGE 156
322 PRESCRIBED OVERDOSE 156
323 PRODUCT PRESCRIBING ERROR 155
324 NEUTROPHIL COUNT DECREASED 154
325 HYPERGLYCAEMIA 153
326 AGRANULOCYTOSIS 152
327 COLITIS 151
328 LIVER DISORDER 151
329 MENTAL IMPAIRMENT 151
330 ROAD TRAFFIC ACCIDENT 151
331 VENTRICULAR FIBRILLATION 150
332 HAEMATOMA 149
333 AFFECT LABILITY 148
334 HYPOTONIA 148
335 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 148
336 NEOPLASM PROGRESSION 148
337 RASH PRURITIC 148
338 WITHDRAWAL SYNDROME 148
339 NYSTAGMUS 147
340 SOPOR 147
341 LIVER INJURY 146
342 ISCHAEMIC STROKE 145
343 JOINT SWELLING 145
344 SWELLING FACE 145
345 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 143
346 HYPERTRANSAMINASAEMIA 143
347 LYMPHADENOPATHY 142
348 PRODUCT QUALITY ISSUE 142
349 SKIN EXFOLIATION 140
350 MULTIPLE SCLEROSIS RELAPSE 138
351 RESPIRATORY ARREST 138
352 APNOEA 137
353 MATERNAL EXPOSURE DURING BREAST FEEDING 137
354 PATENT DUCTUS ARTERIOSUS 137
355 NEPHROLITHIASIS 136
356 HYPERKALAEMIA 135
357 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 135
358 HYPOTHERMIA 134
359 RESPIRATORY DEPRESSION 134
360 TORSADE DE POINTES 134
361 DYSTONIA 133
362 COAGULOPATHY 132
363 SEIZURE CLUSTER 132
364 DRY SKIN 131
365 FOETAL GROWTH RESTRICTION 131
366 THROMBOSIS 131
367 CARDIAC DISORDER 130
368 PSYCHIATRIC SYMPTOM 130
369 CENTRAL NERVOUS SYSTEM LESION 129
370 HAEMATOCHEZIA 129
371 LIVER FUNCTION TEST ABNORMAL 129
372 PULMONARY OEDEMA 129
373 BRONCHITIS 128
374 DRUG WITHDRAWAL CONVULSIONS 128
375 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 128
376 PNEUMONITIS 128
377 SWELLING 128
378 HAEMATEMESIS 127
379 JAUNDICE 127
380 PRESCRIBED UNDERDOSE 127
381 ANAPHYLACTIC REACTION 126
382 ELECTROLYTE IMBALANCE 126
383 HYPERNATRAEMIA 126
384 BRAIN NEOPLASM 125
385 DYSURIA 125
386 HYPOPHAGIA 125
387 THERAPY CESSATION 125
388 EMOTIONAL DISORDER 124
389 EXPOSURE VIA BREAST MILK 123
390 HAEMODYNAMIC INSTABILITY 123
391 HAEMORRHAGE INTRACRANIAL 123
392 ASPIRATION 122
393 ATONIC SEIZURES 122
394 EYE MOVEMENT DISORDER 122
395 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 122
396 SHOCK 122
397 DEMENTIA 121
398 DIABETES MELLITUS 121
399 GAIT INABILITY 120
400 HYPOSPADIAS 120
401 PRODUCTIVE COUGH 120
402 SIMPLE PARTIAL SEIZURES 120
403 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 120
404 TRANSIENT ISCHAEMIC ATTACK 120
405 DRUG WITHDRAWAL SYNDROME 119
406 ENCEPHALITIS AUTOIMMUNE 119
407 SPINA BIFIDA 119
408 THERAPEUTIC RESPONSE UNEXPECTED 119
409 NIGHTMARE 118
410 TALIPES 118
411 ENCEPHALITIS 117
412 DYSMORPHISM 116
413 PANCREATITIS ACUTE 116
414 SKIN LESION 116
415 ACUTE RESPIRATORY DISTRESS SYNDROME 115
416 CELLULITIS 115
417 DYSPHONIA 115
418 SKIN DISCOLOURATION 115
419 WRONG PATIENT RECEIVED PRODUCT 114
420 ATRIOVENTRICULAR BLOCK COMPLETE 113
421 MATERNAL DRUGS AFFECTING FOETUS 113
422 NEUROLEPTIC MALIGNANT SYNDROME 113
423 SURGERY 113
424 CHEST DISCOMFORT 112
425 EMOTIONAL DISTRESS 112
426 POLLAKIURIA 112
427 PRODUCT AVAILABILITY ISSUE 112
428 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 110
429 HAEMATURIA 110
430 INTERNATIONAL NORMALISED RATIO INCREASED 110
431 DRY MOUTH 109
432 HYPOTHYROIDISM 109
433 INJURY 109
434 OSTEOPOROSIS 109
435 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 109
436 RED BLOOD CELL COUNT DECREASED 109
437 SINUSITIS 109
438 WHITE BLOOD CELL COUNT INCREASED 109
439 AMMONIA INCREASED 108
440 CLOSTRIDIUM DIFFICILE INFECTION 108
441 INTELLECTUAL DISABILITY 108
442 CATARACT 107
443 POLYDACTYLY 107
444 SINUS BRADYCARDIA 107
445 UPPER RESPIRATORY TRACT INFECTION 107
446 CEREBRAL INFARCTION 106
447 CYTOMEGALOVIRUS INFECTION 106
448 DRUG DEPENDENCE 106
449 HYPERBILIRUBINAEMIA 106
450 MUSCLE RIGIDITY 106
451 PERICARDIAL EFFUSION 106
452 CEREBRAL ATROPHY 105
453 EJECTION FRACTION DECREASED 105
454 RECTAL HAEMORRHAGE 105
455 SINUS TACHYCARDIA 105
456 CAESAREAN SECTION 104
457 FLUSHING 104
458 ASTHMA 103
459 FRACTURE 103
460 INFUSION RELATED REACTION 103
461 NECK PAIN 103
462 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 102
463 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 102
464 FEAR 101
465 HYDROCEPHALUS 101
466 INFANTILE SPASMS 101
467 LOWER RESPIRATORY TRACT INFECTION 101
468 PRODUCT TASTE ABNORMAL 101
469 SWOLLEN TONGUE 101
470 HERPES ZOSTER 100
471 STAPHYLOCOCCAL INFECTION 100
472 BLOOD ALKALINE PHOSPHATASE INCREASED 99
473 INJECTION SITE PAIN 99
474 LUNG DISORDER 99
475 RENAL FAILURE ACUTE 99
476 DRUG EFFECT INCOMPLETE 98
477 POOR QUALITY SLEEP 98
478 ECZEMA 97
479 HYPERTHERMIA 97
480 PARKINSON^S DISEASE 97
481 PETECHIAE 97
482 RESPIRATORY ACIDOSIS 97
483 RESPIRATORY TRACT INFECTION 97
484 MAJOR DEPRESSION 96
485 BLOOD SODIUM DECREASED 95
486 CLEFT PALATE 95
487 CRYPTORCHISM 95
488 OBSESSIVE-COMPULSIVE DISORDER 95
489 ACUTE PSYCHOSIS 94
490 CLOSTRIDIUM DIFFICILE COLITIS 94
491 COMPLEX PARTIAL SEIZURES 94
492 EPILEPTIC ENCEPHALOPATHY 94
493 POLYNEUROPATHY 94
494 THROMBOTIC MICROANGIOPATHY 94
495 DRUG LEVEL BELOW THERAPEUTIC 93
496 CYANOSIS 92
497 FEELING DRUNK 92
498 HEPATIC STEATOSIS 92
499 WHEEZING 92
500 DYSSTASIA 91
501 MOTOR DYSFUNCTION 91
502 RHINORRHOEA 91
503 SALIVARY HYPERSECRETION 91
504 SENSORY DISTURBANCE 91
505 BRADYPHRENIA 90
506 DEVELOPMENTAL HIP DYSPLASIA 90
507 PROPOFOL INFUSION SYNDROME 90
508 NEUROLOGICAL DECOMPENSATION 89
509 DYSGEUSIA 88
510 FEEDING DISORDER 88
511 MULTIPLE SCLEROSIS 88
512 ORTHOSTATIC HYPOTENSION 88
513 WOUND 88
514 DISSEMINATED INTRAVASCULAR COAGULATION 87
515 MENINGITIS ASEPTIC 87
516 PHOTOPHOBIA 87
517 TOXIC SKIN ERUPTION 87
518 AUTOIMMUNE HEPATITIS 86
519 ERECTILE DYSFUNCTION 86
520 LIVER FUNCTION TEST INCREASED 86
521 PALLOR 86
522 REBOUND EFFECT 86
523 SUICIDAL BEHAVIOUR 86
524 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 85
525 LYMPHOCYTE COUNT DECREASED 85
526 SLEEP APNOEA SYNDROME 85
527 VIRAL INFECTION 85
528 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 84
529 BONE MARROW FAILURE 84
530 BRAIN OPERATION 84
531 TINNITUS 84
532 BLINDNESS 83
533 BLOOD BILIRUBIN INCREASED 83
534 FOETAL MALFORMATION 83
535 INTESTINAL ISCHAEMIA 83
536 MYELOSUPPRESSION 83
537 CARDIOGENIC SHOCK 82
538 CARDIOTOXICITY 82
539 POTENTIATING DRUG INTERACTION 82
540 TACHYPNOEA 82
541 AKATHISIA 81
542 HEART RATE DECREASED 81
543 HEPATIC ENCEPHALOPATHY 81
544 INFLAMMATION 81
545 NEURALGIA 81
546 PRODUCT ODOUR ABNORMAL 81
547 PSYCHOMOTOR SKILLS IMPAIRED 81
548 BACTERAEMIA 80
549 BLOOD LACTIC ACID INCREASED 80
550 BLOOD POTASSIUM DECREASED 80
551 END STAGE RENAL DISEASE 80
552 FUNGAL INFECTION 80
553 MUSCULOSKELETAL PAIN 80
554 PRE-ECLAMPSIA 80
555 RESPIRATORY DISORDER 80
556 ACNE 79
557 RENAL DISORDER 79
558 SYSTEMIC LUPUS ERYTHEMATOSUS 79
559 CHOLESTATIC LIVER INJURY 78
560 CYSTITIS 78
561 CYTOPENIA 78
562 DEPRESSIVE SYMPTOM 78
563 FLATULENCE 78
564 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 78
565 PSORIASIS 78
566 STUPOR 78
567 THERAPEUTIC PRODUCT EFFECT DECREASED 78
568 BODY TEMPERATURE INCREASED 77
569 HAEMATOCRIT DECREASED 77
570 INTESTINAL OBSTRUCTION 77
571 MIDDLE INSOMNIA 77
572 NEUTROPENIC SEPSIS 77
573 PARALYSIS 77
574 RESPIRATORY DISORDER NEONATAL 77
575 VITAMIN D DEFICIENCY 77
576 ANHEDONIA 76
577 BIPOLAR DISORDER 76
578 CEREBRAL DISORDER 76
579 EATING DISORDER 76
580 GASTRITIS 76
581 GLIOBLASTOMA 76
582 PRODUCT PRESCRIBING ISSUE 76
583 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 76
584 ERYTHEMA MULTIFORME 75
585 RASH GENERALISED 75
586 ASCITES 74
587 BRADYCARDIA NEONATAL 74
588 EYE PAIN 74
589 FEMUR FRACTURE 74
590 LIMB INJURY 74
591 LIP SWELLING 74
592 ATRIOVENTRICULAR BLOCK 73
593 AUTONOMIC NERVOUS SYSTEM IMBALANCE 73
594 DISCOMFORT 73
595 HEMIPLEGIA 73
596 HYPOACUSIS 73
597 HYPOGAMMAGLOBULINAEMIA 73
598 IMPULSIVE BEHAVIOUR 73
599 BLOOD CHOLESTEROL INCREASED 72
600 VISUAL ACUITY REDUCED 72
601 WRONG PRODUCT ADMINISTERED 72
602 ABNORMAL DREAMS 71
603 BONE PAIN 71
604 BRADYKINESIA 71
605 BRAIN INJURY 71
606 HYPOALBUMINAEMIA 71
607 JOINT INJURY 71
608 MALABSORPTION 71
609 POSTICTAL PSYCHOSIS 71
610 CATATONIA 70
611 EXCESSIVE EYE BLINKING 70
612 GAZE PALSY 70
613 HYPOKINESIA 70
614 PSYCHOMOTOR RETARDATION 70
615 SCREAMING 70
616 CONTRAINDICATED PRODUCT ADMINISTERED 69
617 FEBRILE CONVULSION 69
618 GUILLAIN-BARRE SYNDROME 69
619 METABOLIC ENCEPHALOPATHY 69
620 PHOTOSENSITIVITY REACTION 69
621 SUBARACHNOID HAEMORRHAGE 69
622 VENOOCCLUSIVE LIVER DISEASE 69
623 CYTOGENETIC ABNORMALITY 68
624 INCONTINENCE 68
625 RESPIRATORY RATE INCREASED 68
626 DERMATITIS ALLERGIC 67
627 EAR INFECTION 67
628 HOT FLUSH 67
629 JOINT DISLOCATION 67
630 PERSECUTORY DELUSION 67
631 AUTISM SPECTRUM DISORDER 66
632 EYE SWELLING 66
633 HYPERTHYROIDISM 66
634 LIMB DISCOMFORT 66
635 MYDRIASIS 66
636 RENAL INJURY 66
637 RESTLESS LEGS SYNDROME 66
638 SELECTIVE EATING DISORDER 66
639 CANDIDA INFECTION 65
640 ENDOTRACHEAL INTUBATION 65
641 HIP FRACTURE 65
642 LACRIMATION INCREASED 65
643 NORMAL NEWBORN 65
644 PEMPHIGOID 65
645 POISONING 65
646 PRODUCT DISPENSING ERROR 65
647 PSEUDOMONAS INFECTION 65
648 ILL-DEFINED DISORDER 64
649 SKIN REACTION 64
650 TRISOMY 21 64
651 VENTRICULAR EXTRASYSTOLES 64
652 ACIDOSIS 63
653 BRAIN HERNIATION 63
654 CARDIAC FAILURE CONGESTIVE 63
655 DEVICE RELATED INFECTION 63
656 EXTRAPYRAMIDAL DISORDER 63
657 FACE OEDEMA 63
658 FLUID RETENTION 63
659 HAEMOLYTIC ANAEMIA 63
660 HYPOTONIA NEONATAL 63
661 ILEUS 63
662 KETOSIS 63
663 NEOPLASM MALIGNANT 63
664 TEMPORAL LOBE EPILEPSY 63
665 ARTHRITIS 62
666 CHOLELITHIASIS 62
667 DRUG WITHDRAWAL SYNDROME NEONATAL 62
668 FEELING HOT 62
669 HYPERCALCAEMIA 62
670 PARAPLEGIA 62
671 RASH MACULAR 62
672 SUSPECTED SUICIDE 62
673 CONJUNCTIVITIS 61
674 DYSPNOEA EXERTIONAL 60
675 GESTATIONAL DIABETES 60
676 HEAD DISCOMFORT 60
677 HOSPICE CARE 60
678 INTESTINAL PERFORATION 60
679 MULTI-ORGAN FAILURE 60
680 NASAL CONGESTION 60
681 PAIN IN JAW 60
682 RASH MORBILLIFORM 60
683 RIB FRACTURE 60
684 URINE OUTPUT DECREASED 60
685 ADRENAL INSUFFICIENCY 59
686 ADVERSE REACTION 59
687 ATRIOVENTRICULAR BLOCK FIRST DEGREE 59
688 BLOOD GLUCOSE DECREASED 59
689 BURNING SENSATION 59
690 CLONIC CONVULSION 59
691 DRUG EFFECT DECREASED 59
692 FOOT FRACTURE 59
693 HAEMOPTYSIS 59
694 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 59
695 PULMONARY HYPERTENSION 59
696 RASH PAPULAR 59
697 CYTOMEGALOVIRUS INFECTION REACTIVATION 58
698 FEELING JITTERY 58
699 GASTROENTERITIS VIRAL 58
700 HYPOVENTILATION 58
701 MOUTH ULCERATION 58
702 NO THERAPEUTIC RESPONSE 58
703 SENSORY LOSS 58
704 SYSTEMIC INFECTION 58
705 AGEUSIA 57
706 BODY TEMPERATURE DECREASED 57
707 CHOLECYSTITIS 57
708 HEPATITIS ACUTE 57
709 HEPATITIS CHOLESTATIC 57
710 INSURANCE ISSUE 57
711 NEW ONSET REFRACTORY STATUS EPILEPTICUS 57
712 STARING 57
713 SUDDEN DEATH 57
714 BEDRIDDEN 56
715 BLOOD LACTATE DEHYDROGENASE INCREASED 56
716 BRAIN FOG 56
717 CHROMATURIA 56
718 HALLUCINATIONS, MIXED 56
719 INTENTIONAL DOSE OMISSION 56
720 SINUS NODE DYSFUNCTION 56
721 SKIN LACERATION 56
722 ATELECTASIS 55
723 BLOOD UREA INCREASED 55
724 CARDIOPULMONARY FAILURE 55
725 CHOKING 55
726 EYE DISORDER 55
727 HYPERTONIA 55
728 OCULAR HYPERAEMIA 55
729 OLIGURIA 55
730 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 55
731 SKIN DISORDER 55
732 ATTENTION DEFICIT HYPERACTIVITY DISORDER 54
733 BLOOD ALBUMIN DECREASED 54
734 CARDIOMYOPATHY 54
735 DIABETIC NEUROPATHY 54
736 HYPOPHOSPHATAEMIA 54
737 INCREASED APPETITE 54
738 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 54
739 PLASMA CELL MYELOMA 54
740 PROTEINURIA 54
741 RASH PUSTULAR 54
742 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 54
743 DIABETES INSIPIDUS 53
744 GASTRIC DISORDER 53
745 HYDRONEPHROSIS 53
746 OSTEOPENIA 53
747 TASTE DISORDER 53
748 CLEFT LIP AND PALATE 52
749 CLONUS 52
750 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52
751 GENERALISED OEDEMA 52
752 PRODUCT DOSE OMISSION IN ERROR 52
753 PURPURA 52
754 TYPE 2 DIABETES MELLITUS 52
755 UPPER LIMB FRACTURE 52
756 WHITE MATTER LESION 52
757 BACTERIAL INFECTION 51
758 BLOOD TRIGLYCERIDES INCREASED 51
759 FLUID INTAKE REDUCED 51
760 FOETAL DEATH 51
761 FRUSTRATION TOLERANCE DECREASED 51
762 LOWER LIMB FRACTURE 51
763 LUNG NEOPLASM MALIGNANT 51
764 ORAL PAIN 51
765 PRODUCT USE COMPLAINT 51
766 SCHIZOPHRENIA 51
767 WOUND INFECTION 51
768 ACCIDENTAL DEATH 50
769 DERMATITIS BULLOUS 50
770 DRY EYE 50
771 HEMIANOPIA 50
772 LABORATORY TEST ABNORMAL 50
773 LANGUAGE DISORDER 50
774 MALNUTRITION 50
775 NEPHROPATHY TOXIC 50
776 POSTICTAL PARALYSIS 50
777 PULMONARY CONGESTION 50
778 SUPRAVENTRICULAR TACHYCARDIA 50
779 THYROID DISORDER 50
780 VANISHING BILE DUCT SYNDROME 50
781 CEREBELLAR ATAXIA 49
782 EOSINOPHIL COUNT INCREASED 49
783 INCOHERENT 49
784 INTERVERTEBRAL DISC PROTRUSION 49
785 MITRAL VALVE INCOMPETENCE 49
786 SEXUAL DYSFUNCTION 49
787 SYNDACTYLY 49
788 TOXIC OPTIC NEUROPATHY 49
789 TRANSFUSION 49
790 TUBEROUS SCLEROSIS COMPLEX 49
791 VAGINAL HAEMORRHAGE 49
792 CARDIOVASCULAR DISORDER 48
793 GLIOBLASTOMA MULTIFORME 48
794 IRON DEFICIENCY ANAEMIA 48
795 LIVER ABSCESS 48
796 LOSS OF LIBIDO 48
797 MELAENA 48
798 MENINGITIS 48
799 RENAL TUBULAR NECROSIS 48
800 TRICUSPID VALVE INCOMPETENCE 48
801 CACHEXIA 47
802 DISABILITY 47
803 DYSGRAPHIA 47
804 FACIAL PARALYSIS 47
805 HEART DISEASE CONGENITAL 47
806 HEPATOMEGALY 47
807 IMPAIRED WORK ABILITY 47
808 MENINGIOMA 47
809 METASTASES TO LIVER 47
810 MICTURITION URGENCY 47
811 PLEOCYTOSIS 47
812 PULMONARY HAEMORRHAGE 47
813 PYLORIC STENOSIS 47
814 SKIN FISSURES 47
815 STRESS CARDIOMYOPATHY 47
816 ACCIDENTAL EXPOSURE TO PRODUCT 46
817 BRADYPNOEA 46
818 BRAIN ABSCESS 46
819 CEREBELLAR ATROPHY 46
820 DIFFUSE LARGE B-CELL LYMPHOMA 46
821 ENTEROCOCCAL INFECTION 46
822 ENTEROCOLITIS 46
823 FANCONI SYNDROME 46
824 HERPES SIMPLEX 46
825 HYDROCELE 46
826 POLYURIA 46
827 POST PROCEDURAL COMPLICATION 46
828 POSTICTAL STATE 46
829 SKIN ULCER 46
830 WEIGHT GAIN POOR 46
831 BLOOD PRESSURE FLUCTUATION 45
832 BLOOD PRESSURE SYSTOLIC INCREASED 45
833 BREAST FEEDING 45
834 CONCUSSION 45
835 DROOLING 45
836 EUPHORIC MOOD 45
837 IMPAIRED QUALITY OF LIFE 45
838 MIXED LIVER INJURY 45
839 MUTISM 45
840 NECROSIS ISCHAEMIC 45
841 OCULOGYRIC CRISIS 45
842 POISONING DELIBERATE 45
843 QUADRIPARESIS 45
844 SPINAL FRACTURE 45
845 VASOPLEGIA SYNDROME 45
846 ANAL INCONTINENCE 44
847 ANENCEPHALY 44
848 ASTERIXIS 44
849 BASAL CELL CARCINOMA 44
850 DIABETIC KETOACIDOSIS 44
851 FIBROMYALGIA 44
852 HYPERCAPNIA 44
853 LIVE BIRTH 44
854 NEUROPSYCHIATRIC SYMPTOMS 44
855 OSTEOARTHRITIS 44
856 RETCHING 44
857 SELF-INJURIOUS IDEATION 44
858 SHOCK HAEMORRHAGIC 44
859 TONGUE BITING 44
860 UPPER GASTROINTESTINAL HAEMORRHAGE 44
861 ARTHROPATHY 43
862 BRAIN NEOPLASM MALIGNANT 43
863 CARDIOMEGALY 43
864 COMMUNICATION DISORDER 43
865 DYSPHEMIA 43
866 ERYSIPELAS 43
867 HICCUPS 43
868 INGUINAL HERNIA 43
869 METASTASES TO BONE 43
870 PRODUCT PACKAGING CONFUSION 43
871 THROMBOCYTOSIS 43
872 ACUTE MYOCARDIAL INFARCTION 42
873 ANGINA PECTORIS 42
874 APLASIA 42
875 BLOOD URINE PRESENT 42
876 BREAST CANCER 42
877 ENTERITIS 42
878 FOOT DEFORMITY 42
879 HEPATIC CIRRHOSIS 42
880 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 42
881 NECROTISING COLITIS 42
882 SEASONAL ALLERGY 42
883 ABSCESS 41
884 BLOOD CALCIUM DECREASED 41
885 BRAIN DEATH 41
886 FULL BLOOD COUNT DECREASED 41
887 GASTROENTERITIS 41
888 HOSTILITY 41
889 INFANTILE APNOEA 41
890 MICROCEPHALY 41
891 NEONATAL RESPIRATORY DISTRESS SYNDROME 41
892 NEUTROPHIL COUNT INCREASED 41
893 PNEUMONIA BACTERIAL 41
894 PNEUMOTHORAX 41
895 POSTURE ABNORMAL 41
896 PRESYNCOPE 41
897 PULMONARY TOXICITY 41
898 PULSELESS ELECTRICAL ACTIVITY 41
899 SPLENOMEGALY 41
900 THROAT IRRITATION 41
901 ABASIA 40
902 ANKLE FRACTURE 40
903 ATRIOVENTRICULAR BLOCK SECOND DEGREE 40
904 CRANIOCEREBRAL INJURY 40
905 DEJA VU 40
906 DRUG ADMINISTRATION ERROR 40
907 DRUG DISPENSING ERROR 40
908 ECCHYMOSIS 40
909 HOMICIDAL IDEATION 40
910 ILEUS PARALYTIC 40
911 LEUKOENCEPHALOPATHY 40
912 LYMPHOMA 40
913 MALIGNANT MELANOMA 40
914 METASTATIC MALIGNANT MELANOMA 40
915 PERITONITIS 40
916 PERSONALITY DISORDER 40
917 PHARYNGITIS 40
918 TARDIVE DYSKINESIA 40
919 TEMPERATURE REGULATION DISORDER 40
920 TRISOMY 18 40
921 ABDOMINAL PAIN LOWER 39
922 ACIDOSIS HYPERCHLORAEMIC 39
923 ANTICOAGULATION DRUG LEVEL ABNORMAL 39
924 BRAIN MALFORMATION 39
925 COVID-19 PNEUMONIA 39
926 DEATH NEONATAL 39
927 DECUBITUS ULCER 39
928 EXOMPHALOS 39
929 FOETAL DISTRESS SYNDROME 39
930 GINGIVAL HYPERTROPHY 39
931 HAEMORRHAGIC STROKE 39
932 INABILITY TO AFFORD MEDICATION 39
933 INJECTION SITE ERYTHEMA 39
934 LENNOX-GASTAUT SYNDROME 39
935 ORAL CANDIDIASIS 39
936 PNEUMOCYSTIS JIROVECII PNEUMONIA 39
937 UROSEPSIS 39
938 VAGAL NERVE STIMULATOR IMPLANTATION 39
939 ACCIDENT 38
940 CONGENITAL HYDRONEPHROSIS 38
941 DEVICE ISSUE 38
942 DIVERTICULITIS 38
943 DRUG DOSE TITRATION NOT PERFORMED 38
944 EXPOSURE DURING BREAST FEEDING 38
945 FACIAL BONES FRACTURE 38
946 HUMERUS FRACTURE 38
947 HYPERPYREXIA 38
948 IMPULSE-CONTROL DISORDER 38
949 KLEBSIELLA INFECTION 38
950 MYOPATHY 38
951 NEOPLASM 38
952 OBSTRUCTIVE AIRWAYS DISORDER 38
953 PARESIS 38
954 PRIAPISM 38
955 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 38
956 PSYCHOTIC SYMPTOM 38
957 RHEUMATOID ARTHRITIS 38
958 SARS-COV-2 TEST POSITIVE 38
959 SKIN ABRASION 38
960 SYSTEMIC CANDIDA 38
961 THERMAL BURN 38
962 BLEPHAROSPASM 37
963 BLOOD MAGNESIUM DECREASED 37
964 BLOOD POTASSIUM INCREASED 37
965 DERMATITIS 37
966 EAR PAIN 37
967 ESCHERICHIA URINARY TRACT INFECTION 37
968 GINGIVAL BLEEDING 37
969 GRAFT VERSUS HOST DISEASE IN SKIN 37
970 HYPERLIPIDAEMIA 37
971 LEFT VENTRICULAR DYSFUNCTION 37
972 METABOLIC DISORDER 37
973 POOR VENOUS ACCESS 37
974 BRADYARRHYTHMIA 36
975 CEREBRAL ISCHAEMIA 36
976 CROHN^S DISEASE 36
977 DISORGANISED SPEECH 36
978 DRUG LEVEL ABOVE THERAPEUTIC 36
979 DRUG TOXICITY 36
980 ECONOMIC PROBLEM 36
981 EPSTEIN-BARR VIRUS INFECTION 36
982 GENE MUTATION 36
983 GLAUCOMA 36
984 HYPERREFLEXIA 36
985 IMPAIRED HEALING 36
986 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36
987 INCREASED TENDENCY TO BRUISE 36
988 LEARNING DISORDER 36
989 LEFT VENTRICULAR HYPERTROPHY 36
990 LIPASE INCREASED 36
991 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 36
992 NEUROLOGICAL SYMPTOM 36
993 TONIC CLONIC MOVEMENTS 36
994 DERMATITIS EXFOLIATIVE GENERALISED 35
995 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 35
996 FEELING COLD 35
997 HAEMORRHOIDS 35
998 HYPERCHOLESTEROLAEMIA 35
999 INITIAL INSOMNIA 35